The presence of the top prescribed pharmaceuticals in treated sewage effluents and receiving waters in Southwest Nova Scotia, Canada
- 663 Downloads
- 17 Citations
Abstract
From a list of the top prescribed drugs in Canada, 11 pharmaceuticals and two metabolites were selected for study in municipal sewage treatment plant effluents and receiving waters. Wastewater samples were collected from 16 wastewater treatment plants across Southwest Nova Scotia including the Annapolis Valley, South Shore, and Metropolitan Halifax. Samples were also collected between 100 and 200 m downstream of effluent outflows. Seven pharmaceuticals were found above μg/L levels with their highest concentrations as follows: metformin (10.6 μg/L), acetaminophen (28.9 μg/L), paraxanthine (18.2 μg/L), cotinine (3.10 μg/L), caffeine (115 μg/L), naproxen (29.1 μg/L), and venlafaxine (2.65 μg/L). Metformin, paraxanthine, caffeine, naproxen, ramipril, and venlafaxine were detected in every wastewater effluent sample. Statistical analysis revealed significant differences in pharmaceutical occurrence by treatment methods, weak dependence of pharmaceutical concentrations on populations, and the co-occurrence of some pharmaceuticals. Experimental results might indicate the limitation of primary only treatment methods in breaking down pharmaceuticals.
Keywords
Pharmaceuticals Effluent Receiving water Treatment methods Rural versus urbanNotes
Acknowledgments
The authors appreciate financial support from Acadia University and Canada Foundation for Innovation (CFI). The authors would also like to thank Brian Crouse and Martin Sichinga for technical assistance. The authors are grateful to numerous STP technicians and engineers who were very helpful in assisting sample collection.
References
- Bendz D, Paxéus NA, Ginn TR, Loge FJ (2005) Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J Hazard Mater 122(3):195–204. doi: 10.1016/j.jhazmat.2005.03.012 CrossRefGoogle Scholar
- Brown K, Ghoshdastidar AJ, Hanmore J, Frazee J, Tong AZ (2013) Membrane bioreactor technology: a novel approach to the treatment of compost leachate. Waste Manag 33(11):2188–2194. doi: 10.1016/j.wasman.2013.04.006 CrossRefGoogle Scholar
- Brun GL, Bernier M, Losier R, Doe K, Jackman P, Lee HB (2006) Pharmaceutically active compounds in Atlantic Canadian sewage treatment plant effluents and receiving waters, and potential for environmental effects as measured by acute and chronic aquatic toxicity. Environ Toxicol Chem 25(8):2163–2176. doi: 10.1897/05-426R.1 CrossRefGoogle Scholar
- Bunch A, Bernot M (2011) Distribution of nonprescription pharmaceuticals in central Indiana streams and effects on sediment microbial activity. Ecotoxicology 20(1):97–109. doi: 10.1007/s10646-010-0560-6 CrossRefGoogle Scholar
- Canadian Institute for Health Information (2012) Drug expenditure in Canada, 1985 to 2011. Ottawa, OntarioGoogle Scholar
- Carballa M, Omil F, Lema JM, Llompart MA, García-Jares C, Rodríguez I, Gomez M, Ternes T (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38(12):2918–2926CrossRefGoogle Scholar
- Carter B, Campeau L (2009) The Top Rx Drugs in Canada. Pharmacy Practice:30–38Google Scholar
- Chen M, Ohman K, Metcalfe C, Ikonomou MG, Amatya PL, Wilson J (2006) Pharmaceuticals and endocrine disruptors in wastewater treatment effluents and in the water supply system of Calgary, Alberta, Canada. Water Qual Res J Can 41(4):351–364Google Scholar
- Comeau F, Surette C, Brun G, Losier R (2008) The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci Total Environ 396(2):132–146. doi: 10.1016/j.scitotenv.2008.02.031 CrossRefGoogle Scholar
- Conkle JL, White JR, Metcalfe CD (2008) Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 73(11):1741–1748. doi: 10.1016/j.chemosphere.2008.09.020 CrossRefGoogle Scholar
- Crouse BA, Ghoshdastidar AJ, Tong AZ (2012) The presence of acidic and neutral drugs in treated sewage effluents and receiving waters in the Cornwallis and Annapolis River watersheds and the Mill CoveSewage Treatment Plant in Nova Scotia, Canada. Environ Res 112(1):92–99. doi: 10.1016/j.envres.2011.11.011 CrossRefGoogle Scholar
- Escher BI, Baumgartner R, Koller M, Treyer K, Lienert J, McArdell CS (2011) Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 45(1):75–92. doi: 10.1016/j.watres.2010.08.019 CrossRefGoogle Scholar
- Gagné F, Blaise C, Fournier M, Hansen P (2006) Effects of selected pharmaceutical products on phagocytic activity in Elliptio complanata mussels. Comp Biochem Physiol C: Toxicol Pharmacol 143(2):179–186. doi: 10.1016/j.cbpc.2006.01.008 Google Scholar
- Gasser G, Pankratov I, Elhanany S, Werner P, Gun J, Gelman F, Lev O (2012) Field and laboratory studies of the fate and enantiomeric enrichment of venlafaxine and O-desmethylvenlafaxine under aerobic and anaerobic conditions. Chemosphere 88(1):98–105. doi: 10.1016/j.chemosphere.2012.02.074 CrossRefGoogle Scholar
- Ghoshdastidar AJ, Tong AZ (2013) Treatment of 2,4-D, mecoprop, and dicamba using membrane bioreactor technology. Environ Sci Pollut Res 20(8):5188–5197. doi: 10.1007/s11356-013-1498-z CrossRefGoogle Scholar
- Ghoshdastidar AJ, Saunders J, Brown K, Tong AZ (2012) Membrane bioreactor treatment of commonly used organophosphate pesticides. J Environ Sci Health B 47(7):742–750. doi: 10.1080/03601234.2012.669334 CrossRefGoogle Scholar
- Griensven JMT, Schoemaker RC, Cohen AF, Luus HG, Seibert-Grafe M, Röthig HJ (1995) Pharmacokinetics, pharmacodynamics and bioavailability of the ACE inhibitor ramipril. Eur J Clin Pharmacol 47(6):513–518. doi: 10.1007/BF00193704 CrossRefGoogle Scholar
- Hillebrand O, Nödler K, Licha T, Sauter M, Geyer T (2012) Caffeine as an indicator for the quantification of untreated wastewater in karst systems. Water Res 46(2):395–402. doi: 10.1016/j.watres.2011.11.003 CrossRefGoogle Scholar
- Jeffrey D (2012) Raw sewage still going in harbour. The Chronicle HeraldGoogle Scholar
- Kim Y, Choi K, Jung J, Park S, Kim P-G, Park J (2007) Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33(3):370–375. doi: 10.1016/j.envint.2006.11.017 CrossRefGoogle Scholar
- Lajeunesse A, Gagnon C, Sauvé S (2008) Determination of basic antidepressants and their N-desmethyl metabolites in raw sewage and wastewater using solid-phase extraction and liquid chromatography–tandem mass spectrometry. Anal Chem 80(14):5325–5333. doi: 10.1021/ac800162q CrossRefGoogle Scholar
- Li X, Zheng W, Kelly WR (2013) Occurrence and removal of pharmaceutical and hormone contaminants in rural wastewater treatment lagoons. Sci Total Environ 445–446:22–28. doi: 10.1016/j.scitotenv.2012.12.035 CrossRefGoogle Scholar
- Marshall J (2008) Disposal of household special wastes. vol 2, March 27, 2008 edn. Statistics CanadaGoogle Scholar
- Nash JP, Kime DE, Van der Ven LTM, Wester PW, Brion F, Maack G, Stahlschmidt-Allner P, Tyler CR (2004) Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 112(17):1725CrossRefGoogle Scholar
- Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, Moeller FG, Ferré S (2013) Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans. Neuropharmacology 67:476–484. doi: 10.1016/j.neuropharm.2012.11.029 CrossRefGoogle Scholar
- Parrott JL, Bennie DT (2009) Life-cycle exposure of fathead minnows to a mixture of six common pharmaceuticals and triclosan. J Toxicol Environ Health A 72(10):633–641. doi: 10.1080/15287390902769428 CrossRefGoogle Scholar
- Pettersson I, Berg C (2007) Environmentally relevant concentrations of ethynylestradiol cause female-biased sex ratios in Xenopus tropicalis and Rana temporaria. Environ Toxicol Chem 26(5):1005–1009. doi: 10.1897/06-464R.1 CrossRefGoogle Scholar
- PDR Staff (2008) Physicians' Desk Reference. PDR NetworkGoogle Scholar
- Rúa-Gómez PC, Guedez AA, Ania CO, Püttmann W (2012) Upgrading of wastewater treatment plants through the use of unconventional treatment technologies: removal of lidocaine, tramadol, venlafaxine and their metabolites. Water 4(3):650–669. doi: 10.3390/w4030650 CrossRefGoogle Scholar
- Scheurer M, Michel A, Brauch H-J, Ruck W, Sacher F (2012) Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment. Water Res 46(15):4790–4802. doi: 10.1016/j.watres.2012.06.019 CrossRefGoogle Scholar
- Ternes T, Bonerz M, Schmidt T (2001) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography–electrospray tandem mass spectrometry. J Chromatogr A 938(1):175–185. doi: 10.1016/S0021-9673(01)01205-5 CrossRefGoogle Scholar
- Thomas PM, Foster GD (2005) Tracking acidic pharmaceuticals, caffeine, and triclosan through the wastewater treatment process. Environ Toxicol Chem 24(1):25–30. doi: 10.1897/04-144R.1 CrossRefGoogle Scholar
- Wilcox JD, Bahr JM, Hedman CJ, Hemming JDC, Barman MAE, Bradbury KR (2009) Removal of organic wastewater contaminants in septic systems using advanced treatment technologies. J Environ Qual 38(1):149–156. doi: 10.2134/jeq2007.0365 CrossRefGoogle Scholar
- Yargeau V, Lopata A, Metcalfe C (2007) Pharmaceuticals in the Yamaska River, Quebec, Canada. Water Qual Res J Can 42(4):231–239Google Scholar